Literature DB >> 21284385

Antitumor agents. 284. New desmosdumotin B analogues with bicyclic B-ring as cytotoxic and antitubulin agents.

Kyoko Nakagawa-Goto1, Pei-Chi Wu, Chin-Yu Lai, Ernest Hamel, Hao Zhu, Liying Zhang, Takashi Kozaka, Emika Ohkoshi, Masuo Goto, Kenneth F Bastow, Kuo-Hsiung Lee.   

Abstract

We previously reported that the biological activity of analogues of desmosdumotin B (1) was dramatically changed depending on the B-ring system. A naphthalene B-ring analogue 3 exerted potent in vitro activity against a diverse panel of human tumor cell lines with GI(50) values of 0.8-2.1 μM. In contrast, 1 analogues with a phenyl B-ring showed unique selective activity against P-glycoprotein (P-gp) overexpressing multidrug resistant cell line. We have now prepared and evaluated 1 analogues with bicyclic or tricyclic aromatic B-ring systems as in vitro inhibitors of human cancer cell line proliferation. Among all synthesized derivatives, 21 with a benzo[b]thiophenyl B-ring was highly active, with GI(50) values of 0.06-0.16 μM, and this activity was not influenced by overexpression of P-gp. Furthermore, 21 inhibited tubulin assembly in vitro with an IC(50) value of 2.0 μM and colchicine binding by 78% as well as cellular microtubule polymerization and spindle formation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21284385      PMCID: PMC3048907          DOI: 10.1021/jm1011947

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  19 in total

Review 1.  Recent progress in discovery and development of antimitotic agents.

Authors:  Alex Kiselyov; Konstantin V Balakin; Sergey E Tkachenko; Nikolay Savchuk; Alexandre V Ivachtchenko
Journal:  Anticancer Agents Med Chem       Date:  2007-03       Impact factor: 2.505

2.  Antitumor agents 259. Design, syntheses, and structure-activity relationship study of desmosdumotin C analogs.

Authors:  Kyoko Nakagawa-Goto; Tzu-Hsuan Chen; Chieh-Yu Peng; Kenneth F Bastow; Jiu-Hong Wu; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2007-06-15       Impact factor: 7.446

Review 3.  New tubulin targeting agents currently in clinical development.

Authors:  Robert O Carlson
Journal:  Expert Opin Investig Drugs       Date:  2008-05       Impact factor: 6.206

Review 4.  Microtubules: a dynamic target in cancer therapy.

Authors:  Eddy Pasquier; Maria Kavallaris
Journal:  IUBMB Life       Date:  2008-03       Impact factor: 3.885

5.  Use of Lawesson's reagent in organic syntheses.

Authors:  Turan Ozturk; Erdal Ertas; Olcay Mert
Journal:  Chem Rev       Date:  2007-09-15       Impact factor: 60.622

Review 6.  Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.

Authors:  Manuel Medarde; Ana B S Maya; Concepción Pérez-Melero
Journal:  J Enzyme Inhib Med Chem       Date:  2004-12       Impact factor: 5.051

7.  Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells.

Authors:  P Verdier-Pinard; J Y Lai; H D Yoo; J Yu; B Marquez; D G Nagle; M Nambu; J D White; J R Falck; W H Gerwick; B W Day; E Hamel
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

8.  Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study.

Authors:  C M Lin; S B Singh; P S Chu; R O Dempcy; J M Schmidt; G R Pettit; E Hamel
Journal:  Mol Pharmacol       Date:  1988-08       Impact factor: 4.436

Review 9.  Combretastatin a-4 analogs as anticancer agents.

Authors:  Anurag Chaudhary; S N Pandeya; P Kumar; P P Sharma; S Gupta; N Soni; K K Verma; G Bhardwaj
Journal:  Mini Rev Med Chem       Date:  2007-12       Impact factor: 3.862

10.  The mechanism of action of colchicine. Binding of colchincine-3H to cellular protein.

Authors:  G G Borisy; E W Taylor
Journal:  J Cell Biol       Date:  1967-08       Impact factor: 10.539

View more
  9 in total

1.  Synthesis of novel spin-labeled derivatives of 5-FU as potential antineoplastic agents.

Authors:  Liu Yang; Mei-Juan Wang; Zhi-Jun Zhang; Susan L Morris-Natschke; Masuo Goto; Jing Tian; Ying-Qian Liu; Chih-Ya Wang; Xuan Tian; Xiao-Ming Yang; Kuo-Hsiung Lee
Journal:  Med Chem Res       Date:  2014-07       Impact factor: 1.965

2.  Antitumor Agents 291 Expanded B-Ring Modification Study of 6,8,8-Triethyl Desmosdumotin B Analogues as Multidrug-Resistance Selective Agents.

Authors:  Kyoko Nakagawa-Goto; Kenneth F Bastow; Emika Ohkoshi; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Med Chem (Los Angeles)       Date:  2011-12-01

Review 3.  An overview of tubulin inhibitors that interact with the colchicine binding site.

Authors:  Yan Lu; Jianjun Chen; Min Xiao; Wei Li; Duane D Miller
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

4.  Triethylated chromones with substituted naphthalenes as tubulin inhibitors.

Authors:  Kyoko Nakagawa-Goto; Yukako Taniguchi; Yurie Watanabe; Akifumi Oda; Emika Ohkoshi; Ernest Hamel; Kuo-Hsiung Lee; Masuo Goto
Journal:  Bioorg Med Chem       Date:  2016-09-25       Impact factor: 3.641

5.  Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ring.

Authors:  Kyoko Nakagawa-Goto; Akifumi Oda; Ernest Hamel; Emika Ohkoshi; Kuo-Hsiung Lee; Masuo Goto
Journal:  J Med Chem       Date:  2015-02-26       Impact factor: 7.446

6.  Dual-functional abeo-taxane derivatives destabilizing microtubule equilibrium and inhibiting NF-κB activation.

Authors:  Yu Zhao; Jia Su; Masuo Goto; Susan L Morris-Natschke; Yan Li; Qin-Shi Zhao; Zhu-Jun Yao; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2013-05-31       Impact factor: 7.446

Review 7.  Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.

Authors:  Gergely Szakács; Matthew D Hall; Michael M Gottesman; Ahcène Boumendjel; Remy Kachadourian; Brian J Day; Hélène Baubichon-Cortay; Attilio Di Pietro
Journal:  Chem Rev       Date:  2014-04-23       Impact factor: 60.622

8.  Discovery and Optimization of Novel 5-Indolyl-7-arylimidazo[1,2-a]pyridine-8-carbonitrile Derivatives as Potent Antitubulin Agents Targeting Colchicine-binding Site.

Authors:  Xin Zhai; Xiaoqiang Wang; Jiao Wang; Jin Liu; Daiying Zuo; Nan Jiang; Tianfang Zeng; Xiuxiu Yang; Tongfei Jing; Ping Gong
Journal:  Sci Rep       Date:  2017-02-27       Impact factor: 4.379

9.  α-Trifluoromethyl Chalcones as Potent Anticancer Agents for Androgen Receptor-Independent Prostate Cancer.

Authors:  Yohei Saito; Atsushi Mizokami; Kouji Izumi; Renato Naito; Masuo Goto; Kyoko Nakagawa-Goto
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.